Global Peptide Based Cancer Therapeutics Market Scenario Highlighting Major Drivers & Trends, 2017-2
The global peptide based cancer therapeutics market will surpass a valuation of US$ 11,160 Mn by 2022-end.
The global peptide based cancer therapeutics market will surpass a valuation of US$ 11,160 Mn by 2022-end.
The global platelet-rich plasma market will touch a value of nearly US$ 391 Mn in the year 2022.
The global vaccine delivery devices market is expected to register a healthy CAGR, and will represent a value of over US$ 4,000 Mn by the end of 2022.
Revenues from global sales of veterinary imaging systems are expected to exceed US$ 2,000 Mn by 2022-end.
This report provides prognosis and analysis of the global Amniocentesis Needle Market. It offers historical data along with forecast data for 2026.
It is also estimated that, over the forecast period, the Angelman syndrome treatment market will witness a moderate growth.
However, increasing risk of bacterial infection in host might restrain the revenue growth in global bacterial antigens market.
The Asia Pacific cephalic disorders treatment market is dominated by China and India and is expected to grow with the fastest CAGR, owing to the expansion of the healthcare industry and economic growth.
Global in vitro diagnostics market will reach US$89,862.2 mn by the end of 2025, from US$55,000 mn in 2016. Between 2017 and 2025.
This report provides prognosis and analysis of the global Cancer Profiling Market. It offers historical data along with forecast data for 2026.
The global cutting balloon market will expand at a miniscule CAGR of 2.4% between 2017 and 2022.
The global drug eluting balloon catheter market is poised to grow reflect a staggering CAGR of 18.3% during the forecast period 2018 and 2022
Mice models have consistently been the more popular mice model types. By the end of 2023, the revenue earned by the inbred mice model segment is expected to reach US$340.6 mn.
The global neurointerventional devices market is expected to represent a value of over US$ 2,000 Mn, registering a robust CAGR growth over the forecast period, 2017 – 2022.
Revenues from the global market for normal balloon catheter will reach nearly US$ 2,000 Mn by 2022-end.
The global scoring balloon catheter market is expected to register a slow CAGR, and will represent a value of more than US$ 200 Mn by the end of 2022.
The global market for stent graft balloon catheter is estimated to exceed revenues worth US$ 1,000 Mn by 2022-end.
The antibiotic-associated diarrhea treatment market in Asia Pacific excluding Japan is expected to grow with a significant CAGR due to expansion of product offerings by key players.
The Bell’s palsy treatment market is expected to witness exponential growth over the forecast period owing the rising prevalence of Bell’s palsy.
Medication involved in benign positional vertigo treatment by drug class are anti-histamine, anti-cholinergic, and anti-depressant or sedative-hypnotics.
The Fact.MR report on global market for breath analyzers projects that by the end of 2022, over US$ 800 Mn worth of breath analyzers will be sold across the globe.
The global market for electrosurgery devices is estimated to exhibit a steady growth, to reach approximately US$ 8,000 Mn in revenues by 2022-end.
Bone growth stimulators facilitate multi-level fusions in bones with high efficiency, playing a pivotal role in spine fusion aftercare of patients. Medical studies are revealing positive outcomes of utilizing electrical bone growth stimulators for spinal fusion process.
North America’s anesthesia machines market is projected to expand at a CAGR of 5.6% over the forecast period.
North America is projected to retain its dominance in the global dermatology devices market, in terms of revenues.